Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 437 results for "cipla"

Cipla to sell BioQuiddity's anaesthetic products in Europe
Livemint.com

Cipla to market BioQuiddity's products in EU

Will launch the 'OneDose ReadyfusOR' pre-filled with Ropivacaine under its own label into the German market late this year BS Reporter | Mumbai Read more on: Cipla | Bioquiddity | Ropivacaine | European Union Related News Cipla Europe NV ... Business Standard India, 12 hours ago
[x]  

207 images for cipla

CIO & Leader, 2 days ago
IT Next, 2 days ago
Livemint.com, 2 days ago
International Business Times India, 1 week ago
IBN Live, 2 weeks ago
Rediff.com, 2 weeks ago
Bio Spectrum Asia, 2 weeks ago
DNA, 1 week ago
Business Today India, 3 weeks ago
Hindu Business Line, 3 weeks ago

Cipla gains 3%, Wipro DRL drag; Nifty still below 7800

Cipla is up 3 percent, followed by Tata Steel, Reliance, Coal India and GAIL. Hindalco, Wipro, MM, Dr Reddy's Labs and Sun Pharma are among the laggards.
 Money Control18 hours ago Metals up; Sensex Nifty sluggish, rain lashes Mumbai  Money Control20 hours ago Cipla sprints up nearly 2% on BSE  Hindu Business Line2 weeks ago Cipla up nearly 2% on BSE  Business Line1 month ago
[x]  
PR Newswire

Cipla and BioQuiddity announce EU Commercial Partnership

It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...
 India Infoline19 hours ago Cipla inks pact with US co for sale of anaesthetic product in EU region  Hindu Business Line19 hours ago Cipla to market BioQuiddity's post-surgical pain management product, OneDose-ReadyfusOR in EU  PharmaBiz20 hours ago
[x]  

Tata Steel firm but off highs on NSE

Cipla held on to its firm undertone at the close of trading on the NSE on Thursday. It finished the day at ₹456.30, up 1.92 per cent on its previous close at ₹447.70. Tata Steel was firm but off its morning highs at ₹553.40. This represented ...
 Hindu Business Line16 hours ago
CIO & Leader

Cipla CIO Arun Gupta quits

Arun Gupta, global Chief Information Officer of Cipla, after spending more than 2 years with the pharma giant, has decided to move on. Thursday will be Gupta's last day in office. His next destination is still unknown. Speaking to ETCIO, Gupta ...
 Economic Times1 day ago Arun Gupta quits as CIO of Cipla  Business Standard2 days ago Arun Gupta to Quit Cipla as CIO  CIO & Leader2 days ago

CNX Pharma index hits new high on strong Q1 performance

Lupin, Dr Reddy's Lab, Cadila Healthcare, Torrent Pharma, Ipca Lab, Cipla and Wockhardt are up 1-5% on NSE.
 Business Standard1 day ago Pharma stocks on a roll; CNX Pharma index hits new high  Business Standard1 day ago Pharma stocks on a roll, BSE Healthcare index hits new high  Business Standard3 weeks ago Pharma stocks in the limelight on BSE  Business Line3 weeks ago
Cyber India Online

Arun Gupta saying Ciao at Cipla

Cipla marked his second stint in the Pharma vertical News | by CIOL Bureau MUMBAI, INDIA: Industry veteran, and CIO at Cipla , Arun Gupta has decided to move on to new contours now. A little birdie tells us thatThursday July ...
 Cyber India Online1 day ago
Livemint.com

More pharma firms trying to settle patent rows via talks

Cipla and F. Hoffmann-La Roche are in talks to settle the Tarceva patent infringement case that dates back to 2008. Photo: S. Kumar/Mint Mumbai: Indian generics or copycat drug makers and multinational pharma companies are increasingly resorting ...
 Livemint.com2 days ago Cipla and Roche to mediate in patent case  Bio Spectrum Asia2 weeks ago Roche and Cipla enters talks with Erlotinib to settle patent row  Economic Times1 month ago Roche and Cipla enter talks to settle Erlotinib patent row  Economic Times1 month ago

Adil Zainulbhai joins Cipla as Independent Director

Details Category: Latest Updates Published on Friday, 25 July 2014 14:00 He was the Chairman of McKinsey India Cipla has appointed Adil Zainulbhai as an independent director on the Board. Zainulbhai retired as Chairman of McKinsey ...
 Express Pharma6 days ago Cipla appoints independent director  Hindu Business Line6 days ago Board of Cipla appoints director  HDFC Securities1 week ago Cipla appoints Adil Zainulbhai as additional director  Equity Bulls1 week ago
[x]  
Livemint.com

Cipla Buys Out Biotech Firm MabPharm

@Cipla_Limited1 Limited, through its wholly owned subsidiary @Meditab Private Limited has hiked its stake to 100% in Goa based biotech firm Mabpharm Private Limited for an undisclosed amount. Cipla previously held 25% stake in the company and with ...
 Deal Curry1 week ago Cipla : buys Goa-based biotech firm  4 Traders1 week ago Cipla acquires balance 75% stake in biotech firm Mabpharm  VC Circle1 week ago Cipla buys remaining 75% stake in Mabpharm  DNA2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less